Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,024,212
+$571 QoQ
Shares Held
84,062
+16.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#957
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SeaCrest Wealth Management, LLC holds $36,014,537 across 11 Drug Manufacturers - General names. PFE ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,553 | $16,255,876 | |
| 2 | JNJ |
Johnson & Johnson
|
20,122 | $5,110,384 | |
| 3 | AMGN |
Amgen Inc
|
13,712 | $4,965,389 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,502 | $2,763,007 | |
| 5 | ABBV |
AbbVie Inc.
|
8,765 | $2,205,624 | |
| 6 | PFE |
Pfizer Inc
This page
|
84,062 | $2,024,212 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,283 | $793,794 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
13,634 | $785,591 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,024,212 | 84,062 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,023,641 | 72,067 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,697,706 | 68,181 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,641,625 | 64,428 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,098,117 | 86,556 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,731,482 | 68,330 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,740,102 | 65,590 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,092,217 | 72,295 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,903,563 | 68,033 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,803,777 | 65,001 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,156,996 | 109,656 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $4,166,550 | 125,612 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,715,287 | 128,552 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $5,020,032 | 123,040 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,724,942 | 131,244 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,810,934 | 132,791 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,367,778 | 140,526 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $7,144,156 | 137,998 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,547,050 | 195,547 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,456,772 | 173,373 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,576,932 | 142,414 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,498,063 | 124,153 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,354,107 | 118,286 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $4,772,977 | 130,054 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,687,550 | 112,769 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $3,560,366 | 109,080 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||